Elsevier

Vaccine

Volume 16, Issue 19, November 1998, Pages 1795-1802
Vaccine

Paper
Opportunities not missed — systematic influenza and pneumococcal immunization in a public inner-city emergency department

https://doi.org/10.1016/S0264-410X(98)00183-2Get rights and content

Abstract

To demonstrate the feasibility of systematic influenza and pneumococcal vaccination in a busy Emergency Department (ED). Setting: A public, inner-city hospital with an annual adult ED census of 120000. 93% of patients are people of color. 78% deny having either government or private insurance. Only 28% of patients report having a primary care provider. Only 15% present with complaints requiring immediate evaluation by a physician. Methods: Two uncontrolled demonstration projects were conducted during two periods, from 10/21/96 through 12/2/96, (during the influenza immunization season) and from 5/27/97 to 7/26/97. During project one, nurses were given standing orders that all non-urgent patients meeting CDC recommended criteria were to be offered immunization against influenza and/or pneumococcus at triage. The date of immunization was entered into unused fields in the computerized patient registration system, making it available system-wide, to all providers having access to billing system terminals. From 11/4 through 11/18, an extra ‘immunization nurse’ was assigned to test for improvement in immunization figures. A time/motion study of the time required for each immunization was conducted using a convenience sample of eight nurses over all three shifts. During project two, responsibility for carrying out standing orders for immunization was transferred to the patient's nurses in the treatment area, and all high-risk patients were made eligible for immunization. An immunization card was issued to the patient at the time of each immunization. A monetary incentive to nurses was used to encourage completion of tracking forms. Computer record-keeping was continued. Results: Both projects required intense supervision to ensure performance. Despite initial resistance, and extreme variation in individual performance, many nurses and physicians became supportive of ED immunization during the two projects. During project one, 2631 patients were screened, and 789 high-risk patients were identified. 1238 patients were immunized against influenza and 374 against pneumococcus. Immunizations per shift per nurse varied from 0 to 24. Median time for immunization was 4 min (range 2–10.) The addition of an extra nurse at triage did not improve performance. During period two, 1907 patients were screened, 1532 high-risk patients were identified, and 1179 patients were immunized against pneumococcus. Conclusion: Systematic ED immunization of highrisk adults is feasible even in a busy public ED setting.

References (36)

  • D.S. Fedson

    Influenza and pneumococcal vaccination of the elderly: Newer vaccines and prospects for clinical benefits at the margin

    Preventive Medicine

    (1994)
  • R.M. Rodriguez et al.

    Emergency department immunization of the elderly with pneumococcal and influenza vaccines

    Annals of Emergency Medicine

    (1993)
  • Centers for Disease Control and Prevention

    Prevention of pneumococcal disease

    MMWR

    (1997)
  • Centers for Disease Control

    Prevention and control of influenza

    MMWR

    (1997)
  • American College of Physicians Task Force on Adult Immunizations

    Guide for Adult Immunizations

  • US Preventive Services Task Force

    Guide to Clinical Preventive Services

    (1996)
  • J.E. Sisk et al.

    Cost effectiveness of vaccination against pneumococcal pneumonia: an update

    Annals of International Medicine

    (1986)
  • C.B. Gable et al.

    Pneumococcal vaccine, efficacy and associated cost savings

    JAMA

    (1990)
  • K.L. Nichol

    The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community

    NEJM

    (1994)
  • K.L. Nichol et al.

    The effectiveness of vaccination against influenza in healthy working adults

    NEJM

    (1995)
  • E.D. Shapiro et al.

    The protective efficacy of polyvalent pneumococcal polysaccharide vaccine

    NEJM

    (1991)
  • J.C. Butler et al.

    Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations

    JAMA

    (1993)
  • R.V. Sims et al.

    The clinical effectiveness of pneumococcal vaccine in the elderly

    Annals of International Medicine

    (1988)
  • D.S. Fedson et al.

    Previous hospital care as a risk factor for pneumonia: implications for immunization with pneumococcal vaccine

    JAMA

    (1982)
  • W.A. Orenstein et al.

    A closer look at adult immunization in the United States

    The Milbank Quarterly

    (1996)
  • General Accounting Office

    Immunization: HHS could do more to increase vaccination among older adults

    GAO/PEMD-95-14

    (1995)
  • National Advisory Committee on Immunization in Canada

    Health Immunization Guide

    (1994)
  • Centers for Disease Control and Prevention et al.

    Healthy People 2000

    (1990)
  • Cited by (0)

    View full text